TCIM
FPRX
TIAA CREF Investment Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $2.78M | Buy |
207,152
+86,110
| +71% | +$1.15M | ﹤0.01% | 1814 |
|
|
2018
Q4 | $1.13M | Buy |
121,042
+53,682
| +80% | +$499K | ﹤0.01% | 2236 |
|
|
2018
Q3 | $938K | Sell |
67,360
-1,762
| -3% | -$24.5K | ﹤0.01% | 2449 |
|
|
2018
Q2 | $1.09M | Sell |
69,122
-4,148
| -6% | -$65.6K | ﹤0.01% | 2456 |
|
|
2018
Q1 | $1.26M | Buy |
73,270
+9,514
| +15% | +$163K | ﹤0.01% | 2322 |
|
|
2017
Q4 | $1.4M | Sell |
63,756
-10,378
| -14% | -$228K | ﹤0.01% | 2303 |
|
|
2017
Q3 | $3.03M | Sell |
74,134
-12,768
| -15% | -$522K | ﹤0.01% | 1923 |
|
|
2017
Q2 | $2.62M | Sell |
86,902
-45,440
| -34% | -$1.37M | ﹤0.01% | 2024 |
|
|
2017
Q1 | $4.78M | Sell |
132,342
-42,334
| -24% | -$1.53M | ﹤0.01% | 1622 |
|
|
2016
Q4 | $8.75M | Sell |
174,676
-8,606
| -5% | -$431K | 0.01% | 1207 |
|
|
2016
Q3 | $9.62K | Sell |
183,282
-587
| -0.3% | -$31 | 0.01% | 1143 |
|
|
2016
Q2 | $7.6M | Buy |
183,869
+42,002
| +30% | +$1.74M | 0.01% | 1237 |
|
|
2016
Q1 | $5.76M | Buy |
141,867
+1,871
| +1% | +$76K | ﹤0.01% | 1421 |
|
|
2015
Q4 | $5.81M | Sell |
139,996
-3,433
| -2% | -$142K | ﹤0.01% | 1460 |
|
|
2015
Q3 | $2.21M | Sell |
143,429
-1,914
| -1% | -$29.5K | ﹤0.01% | 2072 |
|
|
2015
Q2 | $3.61M | Buy |
145,343
+25,849
| +22% | +$642K | ﹤0.01% | 1916 |
|
|
2015
Q1 | $2.73M | Buy |
119,494
+62,654
| +110% | +$1.43M | ﹤0.01% | 2032 |
|
|
2014
Q4 | $1.54M | Sell |
56,840
-6,467
| -10% | -$175K | ﹤0.01% | 2412 |
|
|
2014
Q3 | $743K | Sell |
63,307
-1,348
| -2% | -$15.8K | ﹤0.01% | 2800 |
|
|
2014
Q2 | $1.01M | Buy |
64,655
+44,305
| +218% | +$689K | ﹤0.01% | 2725 |
|
|
2014
Q1 | $400K | Buy |
20,350
+5,200
| +34% | +$102K | ﹤0.01% | 3003 |
|
|
2013
Q4 | $254K | Buy |
+15,150
| New | +$254K | ﹤0.01% | 3070 |
|